1. Switzerland Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Galenica AG

Galenica AG

99.48
USD
+1.21
(+1.23%)
5.60BMarket Cap
Mar 09Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
56.53
58.3
60.69
64.13
64.45
67
70.4
77.36
72.15
75.15
78.67
82.97
- -
Basic EPS, GAAP
- -
1.64
1.62
1.67
2.43
3
2.54
3.48
3.38
3.32
5.72
3.67
3.63
- -
Free Cash Flow per Basic Share
- -
0.85
1.77
2.44
1.85
2.57
4
3.41
5.51
3.36
3
3.86
4.9
- -
Dividend per Share
- -
1.08
0.92
0.92
- -
1.65
1.7
1.81
1.81
2.11
2.21
2.21
2.31
- -
Book Value per Share
4.19
4.61
5.08
6.59
17.49
18.9
20.14
21.16
24.73
25
29.53
31.08
29.74
28.34
Tangible Book Value per Share
-7.9
-7.86
-7.4
-6.27
3.35
3.29
2.98
2.65
4.17
2.92
7.88
8.69
1.37
-0.36
Basic Weighted Avg Shares
50
50
50
50
49
49
49
49
50
50
50
50
50
50
Sales/Revenue/Turnover
- -
2,826
2,915
3,035
3,141
3,165
3,301
3,480
3,835
3,588
3,746
3,921
4,136
- -
Operating Margin (%)
- -
3.72
3.78
3.77
4.04
3.26
4.88
5.93
4.94
5.18
5.07
5.21
5.47
- -
Depreciation Expense
- -
41
41
42
40
41
91
96
98
100
103
110
116
- -
Net Income, GAAP
- -
82
81
83
119
148
125
172
168
165
285
183
181
- -
Effective Tax Rate (%)
- -
16.35
18.59
20.04
15.04
- -
23.31
17.2
17.16
17.02
15
14.4
17.31
- -
Profit Margin (%)
- -
2.9
2.78
2.75
3.78
4.66
3.79
4.95
4.37
4.6
7.62
4.67
4.38
- -
Working Capital
143
156
192
250
330
339
269
265
299
97
261
300
137
73
LT Debt
764
764
764
765
382
- -
563
551
173
183
186
183
189
175
Total Equity
220
240
259
334
862
934
1,000
1,053
1,234
1,249
1,475
1,552
1,485
1,415
Return on Invested Capital (%)
- -
8.27
8.28
7.54
8.84
- -
10.18
10.8
10.97
11.28
10.52
10.56
10.71
- -
Return on Capital (%)
- -
8.45
8.42
7.64
8.92
- -
10.14
10.8
11.02
11.48
18.32
11.04
10.87
- -
Return on Common Equity (%)
- -
37.19
33.5
28.58
20.02
16.52
13
16.88
14.74
13.35
21.01
12.12
11.95
- -

Capital Structure

CHF

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
53
55
55
LT Borrowings
- -
- -
- -
LT Finance Leases
183
189
175
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
50
50
50
Market Capitalization
- -
4,602
4,523

Working Capital

CHF

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
1,084
1,070
1,115
Cash, Cash Equivalents & STI
67
116
40
Accounts Receivable, Net
623
461
630
Inventories
358
385
396
Total Current Liabilities
840
933
1,043
Payables & Accruals
- -
- -
- -
ST Debt
53
55
55
Deferred Revenue
- -
- -
- -

Growth Rates

CHF

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
24.49%
7.47%
-4.31%
Free Cash Flow
16.12%
13.62%
26.86%
Net Income, GAAP
12.37%
6.35%
-1.01%
Sales/Revenue/Turnover
3.64%
3.66%
5.47%
Total Cash Common Dividend
- -
5.41%
4.48%

Semi-annual Revenue

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
3,921
2025
- -
- -
4,136
2026
- -
- -
- -

Semi-annual Earnings Per Share

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
3.67
2025
- -
- -
3.63
2026
- -
- -
- -

Semi-annual Dividends Per Share

CHF

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
2.21
2025
- -
- -
2.31
2026
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Marc Werner
Full Time Employees
6,558
Sector
Distribution services
Industry
Medical distributors
Address
Untermattweg 8 Bern BE Switzerland 3027
IPO Date
Apr 7, 2017
Website
galenica.com
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Galenica AG (GALE.SW) operates as a leading Swiss healthcare group focused on retail pharmacy, wholesale distribution, and healthcare services. The company offers a comprehensive range of pharmaceutical products and services through its pharmacy retail network under the Amavita, TopPharm, and Sun Store brands; wholesale distribution via Galenica Santé; and specialized healthcare solutions including online pharmacy services via Zur Rose, nursing homes, and medical technology products. It serves consumers, healthcare professionals, and institutions across Switzerland, with operations concentrated in the domestic market and select European wholesale activities. Founded in 2005 and headquartered in Bern, Switzerland, Galenica AG structures its business into three main segments: Retail with over 700 pharmacies; Wholesale, distributing pharmaceuticals, medical devices, and consumer health products; and Services, encompassing e-commerce platforms, logistics, and care facilities targeting private patients, hospitals, and clinics. In recent developments, Galenica AG completed the acquisition of a majority stake in a leading Swiss online pharmacy platform in 2024, enhancing its digital health offerings; announced a strategic partnership with a major pharmaceutical manufacturer for exclusive distribution rights in early 2025; and launched expanded telehealth services integrated into its retail network amid growing demand for remote care solutions. These initiatives reflect the company's shift toward digital transformation and service diversification, including a CHF 150 million investment in logistics infrastructure announced in late 2024 to support expanded wholesale operations. No significant name changes or reorganizations have occurred in the past two years.

Company News

Company News APIChatGPT

  • seekingalpha.com

    Galenica AG (GALNF) Q2 2026 Earnings Call Transcript

  • seekingalpha.com

    Galenica AG (GALNF) Q4 2025 Earnings Call Transcript